Publications
Genentech scientists are encouraged to be creative and active members of the scientific community. We are proud of our publication record in Science, Nature, Cell, and other prestigious peer-reviewed journals, where our annual output consistently rivals or surpasses that of the top academic institutions.
|
IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis
Journal of Neuroimmunology, ISSN: 01655728
|
|
The Lancet Oncology, ISSN: 14745488 14702045
|
|
Effects of PI3K Inhibition on Afucosylated Antibody-Driven FcγRIIIa Events and Phospho-S6 Activity in NK Cells
Journal of Immunology,
|
|
The Lancet Oncology, ISSN: 14745488 14702045
|
|
Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations
The Lancet Haematology,
|
|
AAPS PharmSciTech, ISSN: 15309932
|
|
Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAFV600 mutation–positive metastatic melanoma treated with vemurafenib ± cobimetinib
European Journal of Cancer, ISSN: 09598049
|
|
Mechanisms of immune-related adverse events associated with immune checkpoint blockade: Using germline genetics to develop a personalized approach
Genome Medicine,
|
|
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
The Lancet, ISSN: 01406736
|
|
Journal of Neuroscience, ISSN: 15292401
|
|
Interlaboratory Comparison of Hydrogen-Deuterium Exchange Mass Spectrometry Measurements of the Fab Fragment of NISTmAb
Analytical Chemistry, ISSN: 00032700
|
|
The Lancet Haematology, ISSN: 23523026
|
|
Journal of Pharmacology and Experimental Therapeutics, ISSN: 15210103
|
|
Cancer Chemotherapy and Pharmacology, ISSN: 14320843 03445704
|
|
A phase 1, randomized, single-ascending-dose study to investigate the safety, tolerability, and pharmacokinetics of DSTA4637S, an anti-staphylococcus aureus thiomab antibody-antibiotic conjugate, in healthy volunteers
Antimicrobial Agents and Chemotherapy, ISSN: 00664804
|
|
Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients
Nature Medicine, ISSN: 10788956
|
|
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
The Lancet Oncology, ISSN: 14702045
|
|
Coexpression of inhibitory receptors enriches for activated and functional CD8+ T cells in murine syngeneic tumor models
Cancer immunology research, ISSN: 23266066
|
|
Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis
Rheumatology,
|
|
Genomic features of exceptional response in vemurafenib cobimetinib–treated patients with BRAFV600-mutated metastatic melanoma
Clinical Cancer Research, ISSN: 10780432
|
|
In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection
Toxicological Sciences,
|
|
Phase I study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (atezolizumab) in advanced solid tumors
Clinical Cancer Research, ISSN: 10780432
|
|
Molecular Genetics and Metabolism Reports, ISSN: 22144269
|
|
Cell Reports, ISSN: 22111247
|
|
IRF2 transcriptionally induces GSDMD expression for pyroptosis
Science Signaling, ISSN: 19450877
|
|
Analytical and Bioanalytical Chemistry, ISSN: 16182650 16182642
|
|
Organic Process Research and Development, ISSN: 1520586X 10836160
|
|
Organic Process Research and Development, ISSN: 1520586X 10836160
|
|
Bioconjugate Chemistry, ISSN: 15204812 10431802
|
|
Blood, ISSN: 15280020
|
|
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) centroid data measured between 3.6 oC and 25.4 OC for the Fab fragment of NiStmab
Journal of Research of the National Institute of Standards and Technology,
|
|
Blood, ISSN: 15280020 00064971
|
|
Drug Metabolism and Disposition, ISSN: 1521009X 00909556
|
|
The Lancet Respiratory Medicine, ISSN: 22132619 22132600
|
|
Journal of Ocular Pharmacology and Therapeutics, ISSN: 15577732 10807683
|
|
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in nonsmall cell lung cancer
PLoS ONE,
|
|
Stability evaluation of hydrogen peroxide uptake samples from monoclonal antibody drug product aseptically filled in vapor phase hydrogen peroxide-sanitized barrier systems: A case study
PDA Journal of Pharmaceutical Science and Technology, ISSN: 10797440
|
|
AAPS Journal, ISSN: 15507416
|
|
Nature Materials, ISSN: 14764660 14761122
|
|
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)
The Lancet Haematology,
|
|
Journal of Immunological Methods, ISSN: 18727905 00221759
|
|
British Journal of Dermatology, ISSN: 13652133 00070963
|
